Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2000

View Archived Issues

Genzyme Molecular Oncology enters into new diagnostic licensing agreements

Compound in cinnamon affects glucose metabolism

Omeprazole infusion reduces recurrent bleeding in peptic ulcer patients

Macrophage-derived chemokine found to inhibit HIV replication in primary macrophages

FDA grants approval for Unithroid as thyroid hormone replacement therapy

Theratechnologies to commence phase II trial of ThGRF1-44 in COPD

CS-866 -- a novel angiotensin II antagonist in the news

Vitamin E may prevent endothelial dysfunction

ETA receptor blockade with LU-135252 assessed in preclinical studies

Neuronal cells safely transplanted in stroke patients

AGE formation inhibitor reduces hypertension and oxidative stress in SHRSP

Morphine tolerance inhibited by metabotropic group II receptor agonists

Inhibition of bacterial metabolism offers new tuberculosis drug target

Soluble guanylyl cyclase activation by YC-1 reduces blood pressure in rats

Naked DNA malaria vaccine phase II clinical trial commences

Oral interferon alfa receives orphan drug status for treatment of oral papillomavirus warts

BioChem Pharma and Adherex establish anticancer agreement

Selenazolidine prodrugs synthesized as potential chemopreventive agents

Novel compound LR-90 shows both hypolipidemic and hypoglycemic activities

Pteridine derivatives reported by K.U. Leuven as treatment for autoimmune disorders

Inhibitors of p38MAP kinase under development at Teikoku Hormone

Cysteine and serine protease inhibitors useful for osteoporosis, etc.

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...